People · Operator

Keith G. Lurie

Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Biotechnology

2
Companies
3
Filings
$10.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
AdvancedCPR Solutions LLCOther Health CareSeries A$9.5M$191.9M2018
Advanced Circulatory Systems IncBiotechnologyPre-Seed$807K$44.6M2009
Operator network

Keith G. Lurie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Philip W. Faris · 2 companies · 1 sharedPhilip W. FarisBarbara G. Lurie · 1 companies · 1 sharedBarbara G. LurieDavid G. Benditt · 1 companies · 1 sharedDavid G. BendittRobert K. Eddy · 1 companies · 1 sharedRobert K. EddyMichael Black · 4 companies · 1 sharedMichael BlackSteven Gold · 4 companies · 1 sharedSteven GoldJOHN F. STAPLETON · 3 companies · 1 sharedJOHN F. STAPLETONJoseph Alexander · 2 companies · 1 sharedJoseph AlexanderDavid Benditt · 1 companies · 1 sharedDavid BendittFred Hunter · 1 companies · 1 sharedFred HunterJohn Greening · 1 companies · 1 sharedJohn GreeningNathan Harris · 1 companies · 1 sharedNathan HarrisAdvancedCPR Solutions LLC · $9.5M raisedAdvancedCPR Solutions…Advanced Circulatory Systems Inc · $0.8M raisedAdvanced Circulatory …Keith G. LurieKL
Keith G. Lurie Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Keith G. Lurie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael Black14
Steven Gold14
JOHN F. STAPLETON13
Joseph Alexander12
Philip W. Faris12
John Greening11
David Benditt11
Nathan Harris11
Barbara G. Lurie11
David G. Benditt11
Robert K. Eddy11
Fred Hunter11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.